Skip to content

Novavax NVAX Total Cost of Revenue

Total Cost of Revenue at other companies

Moderna logo
ModernaMRNA
$955M+961%
Merck & Co. logo
Merck & Co.MRK
$4.2B+22.7%
ALN
Alnylam PharmaceuticalsALNY
$207.52M+196%
Gilead Sciences logo
Gilead SciencesGILD
$1.45B-6.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$238K+310%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$5.38M+17.7%

Segments

By segment

See full
Reportable Segment$30.7M+117%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's total cost of revenue?
Novavax (NVAX) reported total cost of revenue of $30.7M in Q1 2026.
How has Novavax's total cost of revenue changed year-over-year?
Novavax's total cost of revenue increased by 117.5% year-over-year, from $14.12M to $30.7M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.